These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28340940)

  • 1. Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration.
    Hanif-Ur-Rehman ; Freitas TE; Gomes RN; Colquhoun A; de Oliveira Silva D
    J Inorg Biochem; 2016 Dec; 165():181-191. PubMed ID: 28340940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel μ-oxo-diruthenium(III,III)-ibuprofen-(4-aminopyridine) chloride derived from the diruthenium(II,III)-ibuprofen paddlewheel metallodrug shows anticancer properties.
    Alves SR; Santos RLSR; Fornaciari B; Colquhoun A; de Oliveira Silva D
    J Inorg Biochem; 2021 Dec; 225():111596. PubMed ID: 34601164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells.
    Alves Rico SR; Abbasi AZ; Ribeiro G; Ahmed T; Wu XY; de Oliveira Silva D
    Nanoscale; 2017 Aug; 9(30):10701-10714. PubMed ID: 28678269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibitory effects of the Diruthenium-Ibuprofen compound, [Ru2Cl(Ibp) 4], in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo.
    Benadiba M; de M Costa I; Santos RL; Serachi FO; de Oliveira Silva D; Colquhoun A
    J Biol Inorg Chem; 2014 Aug; 19(6):1025-35. PubMed ID: 24824561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells.
    Alves SR; Colquhoun A; Wu XY; de Oliveira Silva D
    J Inorg Biochem; 2020 Apr; 205():110984. PubMed ID: 31927403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel ruthenium-gamma-linolenic complex [Ru(2)(aGLA)(4)Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro.
    Ribeiro G; Benadiba M; de Oliveira Silva D; Colquhoun A
    Cell Biochem Funct; 2010 Jan; 28(1):15-23. PubMed ID: 19927275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of a diruthenium-ibuprofenato complex comparing its anti-inflammatory activity with that of a copper(II)-ibuprofenato complex.
    Andrade A; Namora SF; Woisky RG; Wiezel G; Najjar R; Sertié JA; de Oliveira Silva D
    J Inorg Biochem; 2000 Jul; 81(1-2):23-7. PubMed ID: 11001427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E series prostaglandins alter the proliferative, apoptotic and migratory properties of T98G human glioma cells in vitro.
    Gomes RN; Colquhoun A
    Lipids Health Dis; 2012 Dec; 11():171. PubMed ID: 23231886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic and mechanistic studies on reactions of diruthenium(II,III) with biologically relevant reducing agents.
    Santos RL; van Eldik R; de Oliveira Silva D
    Dalton Trans; 2013 Dec; 42(48):16796-805. PubMed ID: 24081178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diruthenium(II-III)-ibuprofen-loaded chitosan-based microparticles and nanoparticles systems: encapsulation, characterisation, anticancer activity of the nanoformulations against U87MG human glioma cells.
    Rehman HU; Fornaciari B; Alves SR; Colquhoun A; de Oliveira Silva D
    J Microencapsul; 2023 Nov; 40(7):549-565. PubMed ID: 37698449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
    Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L
    Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells.
    Teixeira RG; Brás AR; Côrte-Real L; Tatikonda R; Sanches A; Robalo MP; Avecilla F; Moreira T; Garcia MH; Haukka M; Preto A; Valente A
    Eur J Med Chem; 2018 Jan; 143():503-514. PubMed ID: 29202411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of C6 rat glioma proliferation by [Ru2Cl(Ibp)4] depends on changes in p21, p27, Bax/Bcl2 ratio and mitochondrial membrane potential.
    Benadiba M; Dos Santos RR; Silva Dde O; Colquhoun A
    J Inorg Biochem; 2010 Sep; 104(9):928-35. PubMed ID: 20605638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
    Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
    J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.
    Meier-Menches SM; Gerner C; Berger W; Hartinger CG; Keppler BK
    Chem Soc Rev; 2018 Feb; 47(3):909-928. PubMed ID: 29170783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization, antiproliferative and anti-metastatic properties of two ruthenium-DMSO complexes containing 2,2'-biimidazole.
    Tan C; Hu S; Liu J; Ji L
    Eur J Med Chem; 2011 May; 46(5):1555-63. PubMed ID: 21354673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
    Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
    Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labile ruthenium(ii) complexes with extended phenyl-substituted terpyridyl ligands: synthesis, aquation and anticancer evaluation.
    Huang H; Zhang P; Chen Y; Ji L; Chao H
    Dalton Trans; 2015 Sep; 44(35):15602-10. PubMed ID: 26245234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
    J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel binuclear μ-oxo diruthenium complexes combined with ibuprofen and ketoprofen: Interaction with relevant target biomolecules and anti-allergic potential.
    Seuanes GC; Moreira MB; Petta T; de Moraes Del Lama MPF; de Moraes LAB; de Oliveira ARM; Naal RMZG; Nikolaou S
    J Inorg Biochem; 2015 Dec; 153():178-185. PubMed ID: 26298864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.